|4Sep 30, 4:17 PM ET

Jeremy M. Sclar 2012 Irrevocable Family Trust 4

4 · ProMIS Neurosciences Inc. · Filed Sep 30, 2025

Insider Transaction Report

Form 4
Period: 2025-07-25
Transactions
  • Purchase

    Warrant to Purchase Common Shares

    2025-07-29+3,139,5333,139,533 total
    Common Shares (3,139,533 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6743,012,785 total
  • Exercise of In-Money

    Tranche A Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6742,315,111 total
  • Exercise of In-Money

    Tranche B Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Tranche C Common Share Purchase Warrants

    2025-07-25697,6740 total
    Common Shares (697,674 underlying)
  • Exercise of In-Money

    Common Shares, no par value

    2025-07-25+697,6743,710,459 total
Footnotes (4)
  • [F1]On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F2]On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F3]On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
  • [F4]On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.

Documents

1 file
  • 4
    tm2523607-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT